Home | Clinical Trials


Therapeutic Areas: Oncology | Pediatrics/Neonatology | Neurology

Neuroblastoma Clinical Trials


A listing of Neuroblastoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Phoenix : Phoenix Children's Hospital

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Phoenix : Phoenix Children's Hospital

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma

Phoenix : Phoenix Children'S Hospital

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

Phoenix : Phoenix Children's Hospital

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

California

San Diego : Rady Children's Hospital

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

San Diego : Rady Children's Hospital

A clinical research study of TPI 287 for the treatment of Neuroblastoma or Medulloblastoma

San Diego : Rady Children's Hospital

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma

San Diego : Rady Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

San Francisco : University of California San Francisco Dept of Pediatic Oncology

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Colorado

Aurora : University of Colorado Health Sciences Center and The Children's Hospital

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

Connecticut

Hartford : Connecticut Children's Hospital

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Hartford : Connecticut Children's Hospital

A clinical research study of TPI 287 for the treatment of Neuroblastoma or Medulloblastoma

Hartford : Connecticut Children's Hospital

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma

Hartford : Connecticut Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Florida

Orlando : Arnold Palmer Hospital for Children- MD Anderson

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Orlando : Arnold Palmer Hospital for Children- MD Anderson

A clinical research study of TPI 287 for the treatment of Neuroblastoma or Medulloblastoma

Orlando : Arnold Palmer Hospital for Children- MD Anderson

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma

Orlando : Arnold Palmer Hospital for Children- MD Anderson

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Georgia

Savannah : Memorial University Medical Center

ACNS0821:Temozolomide With Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial

Atlanta : Children's Healthcare of Atlanta Dept of Oncology

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Hawaii

Honolulu : Kapiolani Medical Center for Women and Children

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Honolulu : Kapiolani Medical Center for Women and Children

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Maryland

Baltimore : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Massachusetts

Boston : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Boston : Dana Farber Cancer Institute SC-7

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Michigan

Grand Rapids : Helen DeVos Children's Hospital

A clinical research study of DFMO and Bortezomib for the treatment of Neuroblastoma- Relapsed and Refractory

Grand Rapids : Helen DeVos Children's Hospital

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Grand Rapids : Helen DeVos Children's Hospital

A clinical research study of TPI 287 for the treatment of Neuroblastoma or Medulloblastoma

Grand Rapids : Helen DeVos Children's Hospital

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma

Grand Rapids : Helen DeVos Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Minnesota

Minneapolis : Children's Hospital and Clinics on Minnesota

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Missouri

Kansas City : Children's Mercy Hospitals and Clinics

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Kansas City : Children's Mercy Hospitals and Clinics

A clinical research study of TPI 287 for the treatment of Neuroblastoma or Medulloblastoma

Kansas City : Children's Mercy Hospitals and Clinics

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma

Kansas City : Children's Mercy Hospitals and Clinics

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Kansas City : Children's Mercy Hospital & Clinics

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

St. Louis : Cardinal Glennon Children's Medical Center

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

St. Louis : Cardinal Glennon Children's Medical Center

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Nevada

Las Vegas : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

New York

Bronx : Children's Hospital at Montefiore

A clinical trial seeking patients for a research study of Aromatherapy Scented Wand and Placebo wand

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using Bevacizumab, Irinotecan and Temozolomide for patients with Neuroblastoma

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

North Carolina

Charlotte : Levine Children's Hospital

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Charlotte : Levine Children's Hospital

A clinical research study of TPI 287 for the treatment of Neuroblastoma or Medulloblastoma

Charlotte : Levine Children's Hospital

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma

Charlotte : Levine Children's Hospital

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Ohio

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

131I-Metaiodobenzylguanidine (MIBG) with Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

131I-MIBG Expanded Access: An Open Label, Expanded Access Protocol Using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients With Refractory Neuroblastoma

Cincinnati : Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation

Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder In Patients with Recurrent or Resistant Neuroblastoma IND# 68,254

Cincinnati : Cincinnati Children's Hospital Medical Center Dept of Oncology

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Oklahoma

Oklahoma City :

Patients are needed to participate in a clinical research study of MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide for Pediatric Solid Tumors

Pennsylvania

Philadelphia : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Pittsburgh : Children's Hospital of Pittsburgh

A clinical trial seeking patients for a research study for the treatment of Neuroblastoma or Opsoclonus-Myoclonus

South Carolina

Charleston : Medical University of South Carolina

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Charleston : Medical University of South Carolina

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Tennessee

Memphis : St. Jude Children's Research Hospital

A clinical trial to evaluate treatments for patients with Pediatric Solid Tumors

Nashville : Vanderbilt-Ingram Cancer Center

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Texas

Austin : Dell Children's Blood and Cancer Center

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Dallas :

Patients are needed to participate in a clinical research study of MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide for Pediatric Solid Tumors

Houston : GSK Investigational Site

A clinical trial to evaluate treatments using GSK525762 for patients with Carcinoma, Midline

Houston : Texas Children's Cancer and Hematology Centers

A Phase 2 clinical study for patients with Neuroblastoma or Medulloblastoma

Utah

Salt Lake City : Primary Children's Hospital

A clinical research study of DFMO for the treatment of Neuroblastoma in Remission

Wisconsin

Milwaukee :

Patients are needed to participate in a clinical research study of MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide for Pediatric Solid Tumors

Belgium

Gent : Investigational Site Number 51

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Canada

Calgary : Alberta Children'S Hospital

Patients are needed to participate in a clinical research study of Cyclophosphamide, Topotecan, and Bevacizumab to evaluate Neuroblastoma or Sarcoma

Toronto : The Hospital for Sick Children

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

China

Beijing : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

Guangzhou : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

Czech Republic

Brno : Investigational Site Number 81

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Denmark

Aarhus : Investigational Site Number 62

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

København Ø : Investigational Site Number 61

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

France

Lyon : Investigational Site Number 42

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Lyon : Institute for Pediatric Hemato-Oncology, Leon Berard Cancer Center

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Lyon Cedex : Novartis Investigative Site

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Nancy : Hôpital d'Enfants, CHU Nancy

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Paris : Novartis Investigative Site

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Paris : Institut Curie

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Villejuif : Institut Gustave Roussy

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Villejuif Cedex : Novartis Investigative Site

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Germany

Frankfurt Am Main : Investigational Site Number 33

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Freiburg : Investigational Site Number 34

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Hannover : Investigational Site Number 31

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Hungary

Budapest : Investigational Site Number 83

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Israel

Petach Tikva : Investigational Site Number 92

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Tel-Aviv : Investigational Site Number 91

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Italy

Genova : Investigational Site Number 21

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Genova : Children's Hospital Largo

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Milan : Istituto Nazionale Tumori

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Monza : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

Padova : Clinica di Oncoematologia

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Torino : l'Azienda Ospedaliera Regina Margherita - Sant Anna

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Japan

Nagoya : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

Korea, Republic of

Seoul : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

Netherlands

Amsterdam : Investigational Site Number 72

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Rotterdam : Investigational Site Number 71

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Russian Federation

Saint-Petersburg : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

Saint-Petersburg : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

Spain

Barcelona : Investigational Site Number 94

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Barcelona : Hospital Universitario Vall D`Hebron

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Esplugues De Llobregat : Investigational Site Number 95

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Madrid : Investigational Site Number 93

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Madrid : Spanish National Cancer Research Centre

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Valencia : Unidad de Oncologia Pediatrica, Hospital Universitario la Fe

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Switzerland

Zurich : Universitäts-Kinderklinik

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Taiwan

Taipei : Pfizer Investigational Site

A clinical research study of Crizotinib for the treatment of Neoplasms Malignant (ALK)

United Kingdom

Birmingham : Investigational Site Number 11

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Glasgow : Investigational Site Number 13

A clinical research study of plerixafor for the treatment of Ewing's Sarcoma/Soft Tissue Sarcoma, Neuroblastoma or Brain Tumors

Sutton : Novartis Investigative Site

A Phase 1 clinical study for patients with Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Sutton : Royal Marsden Hospital

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors